financetom
Business
financetom
/
Business
/
Patanjali Foods plans to go big on plantations to cut edible oil imports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Patanjali Foods plans to go big on plantations to cut edible oil imports
Sep 16, 2022 9:49 AM

Yoga guru Baba Ramdev said at a press conference in Delhi that his Patanjali group is working on oil plantations in 11 states, with big focus areas being the North East, Andhra, Telangana and Karnataka.

Share Market Live

NSE

He also announced the initial public offering (IPO) plans for four Patanjali group companies over the next five years.

“There is a strong array of companies which are there. We are doing our own work, they are doing their own work. The market is growing overall, so there is a lot of space and room for growth for all the companies. We will be very supportive of everyone’s efforts but we will continue growing ourselves quite aggressively,” Sanjeev Asthana, CEO of Patanjali Foods, told CNBC-TV18.

While addressing the conference, Ramdev also mentioned that as part of the Vision 2027 for Patanjali Group, the brand has aggressive plans for oilseeds, which involves setting up multiple nurseries and oil processing units.

Also read: Patanjali IPO: A look at India’s fastest growing FMCG brand’s journey

Patanjali is also looking to set up seed gardens and make big investments in the palm oil business.

“To become self-reliant in palm oil, Patanjali group has announced plans to plant palm trees on more than 15 lakh acres of land. These trees will be planted in 55 districts of 11 states,” said Ramdev.

In 5-7 years, the aim is to earn an annual return of Rs 2,000 crore. In addition, the income will keep flowing for 40 years after the palm trees are planted.

Also read:Patanjali group to have 4 IPOs in the next 5 years announces Baba Ramdev

(Edited by : Shoma Bhattacharjee)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved